Your browser doesn't support javascript.
loading
Apoptosis inhibitor TRIAP1 is a novel effector of drug resistance.
Adams, Caroline; Cazzanelli, Giulia; Rasul, Sabeena; Hitchinson, Ben; Hu, Yunhui; Coombes, R Charles; Raguz, Selina; Yagüe, Ernesto.
Afiliação
  • Adams C; Cancer Research Centre, Division of Cancer, Imperial College London, Hammersmith Hospital Campus, London W12 0NN, UK.
  • Cazzanelli G; Cancer Research Centre, Division of Cancer, Imperial College London, Hammersmith Hospital Campus, London W12 0NN, UK.
  • Rasul S; Cancer Research Centre, Division of Cancer, Imperial College London, Hammersmith Hospital Campus, London W12 0NN, UK.
  • Hitchinson B; Cancer Research Centre, Division of Cancer, Imperial College London, Hammersmith Hospital Campus, London W12 0NN, UK.
  • Hu Y; Cancer Research Centre, Division of Cancer, Imperial College London, Hammersmith Hospital Campus, London W12 0NN, UK.
  • Coombes RC; Cancer Research Centre, Division of Cancer, Imperial College London, Hammersmith Hospital Campus, London W12 0NN, UK.
  • Raguz S; Institute of Clinical Sciences, Imperial College London, Hammersmith Hospital Campus, London W12 0NN, UK.
  • Yagüe E; Cancer Research Centre, Division of Cancer, Imperial College London, Hammersmith Hospital Campus, London W12 0NN, UK.
Oncol Rep ; 34(1): 415-22, 2015 Jul.
Article em En | MEDLINE | ID: mdl-25998939

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Doxorrubicina / Resistencia a Medicamentos Antineoplásicos / Peptídeos e Proteínas de Sinalização Intracelular / Antibióticos Antineoplásicos Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Doxorrubicina / Resistencia a Medicamentos Antineoplásicos / Peptídeos e Proteínas de Sinalização Intracelular / Antibióticos Antineoplásicos Idioma: En Ano de publicação: 2015 Tipo de documento: Article